Direct comparison
Ex Vivo vs In Vitro: Definitions and Trade-offs
Ex vivo vs in vitro: NCI definitions side by side, plus two published studies showing the trade-off between tissue architecture and throughput.
Written and maintained by CASRAI Editorial Board
Last updated
Ask CASRAI · free to try
Ask about Ex Vivo vs In Vitro: Definitions and Trade-offs
Ask your first 2 questions free below. Subscribers get 150 a day for $29 a month.
An AI assistant specialized in research administration. It cites the sources behind every answer, labels web answers and says when it can't answer.
Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.
Works on this site and inside Claude, Cursor and the AI tools you already use.
Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.
How do Ex vivo, In vitro compare side by side?
The table below compares Ex vivo, In vitro across 10 procurement-relevant dimensions, from nci definition through source.
Side-by-side comparison
| Dimension | Ex vivo | In vitro |
|---|---|---|
| NCI definition | "Outside of the living body." Refers to a procedure in which an organ, cells, or tissue are taken from a living body for a treatment or procedure, and then returned to the living body. | "In the laboratory (outside the body)." The opposite of in vivo (in the body). |
| Where the work happens | Outside the body, on tissue or an organ taken from a living body. | In the laboratory, outside the body. |
| Typical material in the studies cited here | Porcine ear skin explants (topical antimicrobial study); perfused human placenta (placental transfer study). | Diffusion and biofilm assays (topical antimicrobial study); BeWo b30 cell insert system (placental transfer study). |
| Tissue structure | Porcine ear skin was chosen as a surrogate for human skin for comparable histological structure and permeability. Perfusion temporarily preserves 3D placental architecture. | The placental study presents the BeWo b30 insert system as an alternative to perfusion, not as a replacement for its 3D architecture. |
| Throughput and availability | Placenta perfusion is hampered by a low success rate, limited availability of tissue, and inability to allow high throughput data collection. | The BeWo b30 insert system may serve as a higher-throughput alternative. |
| Stated limitation | The porcine ear model is an explant lacking active blood flow, so it cannot account for systemic clearance, inflammatory cell recruitment, or dynamic physiological tissue repair. | Not stated as a general limitation in these sources; the skin study uses in vitro assays as the first tier before tissue and animal models. |
| Place in a study design | Middle tier in the skin study: in vitro assays, then ex vivo tissue, then in vivo (Galleria mellonella). Results were concordant across tiers. | First tier in the skin study, before ex vivo tissue and in vivo testing. |
| Standing in its field | Ex vivo human placenta perfusion is considered the gold standard in placental transfer research (as stated in that paper). | Positioned in that paper as a higher-throughput alternative to the gold-standard perfusion model. |
| When to pick | Pick when intact tissue architecture is central to the question and tissue is available. | Pick when throughput or availability limits the use of tissue, or as an early screening tier. |
| Source | NCI Dictionary of Cancer Terms (read 2026-11-07); Sci Rep 2026, PMC13578364; Arch Toxicol 2026, PMC13453992 (doi 10.1007/s00204-026-04418-8). | Same three sources. |
Common questions
Common questions about Ex vivo vs In vitro
Is ex vivo the same as in vitro?
+
Not always. NCI defines ex vivo as outside of the living body, referring to a procedure in which an organ, cells or tissue are taken from a living body for a treatment or procedure and then returned. NCI defines in vitro as in the laboratory (outside the body). In research papers, ex vivo commonly describes explants or perfused organs and in vitro describes cell or assay systems, as in the two 2026 studies cited on this page.
What is the difference between in vitro, ex vivo and in vivo?
+
NCI defines in vivo as in the body, the opposite of in vitro. Ex vivo sits between them in the studies cited here: tissue is taken from a living body and studied outside it. In the topical antimicrobial study, the tiers were in vitro assays, then ex vivo porcine skin, then in vivo testing in Galleria mellonella.
What is a limitation of an ex vivo explant model?
+
The porcine ear skin explant in the Sci Rep 2026 study lacks active blood flow, so it cannot account for systemic clearance, inflammatory cell recruitment or dynamic physiological tissue repair.
Why use an in vitro cell model instead of ex vivo tissue?
+
In the placental transfer study, ex vivo perfusion is described as hampered by low success rate, limited tissue availability and inability to allow high throughput. The in vitro BeWo b30 insert system may serve as a higher-throughput alternative.
Going deeper
